Scandinavian Journal of Gastroenterology · 2015 · 40 citations · 21 references
MedicineSurgeryEmergency SurgeryGastroenterologyVascular SurgeryAcute Gastrointestinal HemorrhageEndoscopic SurgeryGastrointestinal BleedingGastrointestinal Bleeding ManagementGastrointestinal EndoscopyHemorrhage ControlAcute Upper Gastrointestinal BleedingBleedingInterventional AngiographyInterventional EmbolizationManagement Of Bleeding ComplicationsTranscatheter Arterial EmbolizationTranscatheter EmbolizationVariceal Bleeding Management
OBJECTIVE: Transcatheter arterial embolization (TAE) is a therapeutic option for endoscopically unmanageable upper gastrointestinal (GI) bleeding. We aimed to assess the efficacy and clinical outcomes of TAE for acute non-variceal upper GI bleeding and to identify predictors of recurrent bleeding within 30 days. MATERIALS AND METHODS: Visceral angiography was performed in 66 patients (42 men, 24 women; mean age, 60.3 ± 12.7 years) who experienced acute non-variceal upper GI bleeding that failed to be controlled by endoscopy during a 7-year period. Clinical information was reviewed retrospectively. Outcomes included technical success rates, complications, and 30-day rebleeding and mortality rates. RESULTS: TAE was feasible in 59 patients. The technical success rate was 98%. Rebleeding within 30 days was observed in 47% after an initial TAE and was managed with re-embolization in 8, by endoscopic intervention in 5, by surgery in 2, and by conservative care in 12 patients. The 30-day overall mortality rate was 42.4%. In the case of initial endoscopic hemostasis failure (n = 34), 31 patients underwent angiographic embolization, which was successful in 30 patients (96.8%). Rebleeding occurred in 15 patients (50%), mainly because of malignancy. Two factors were independent predictors of rebleeding within 30 days by multivariate analysis: coagulopathy (odds ratio [OR] = 4.37; 95% confidence interval [CI]: 1.25-15.29; p = 0.021) and embolization in ≥2 territories (OR = 4.93; 95% CI: 1.43-17.04; p = 0.012). Catheterization-related complications included hepatic artery dissection and splenic embolization. CONCLUSION: TAE controlled acute non-variceal upper GI bleeding effectively. TAE may be considered when endoscopic therapy is unavailable or unsuccessful. Correction of coagulopathy before TAE is recommended.
21
Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom
Tim Rockall, Richard F. Logan, Hugh Devlin et al. · BMJ · 1995 · 914 citations · Full text
The role of endoscopy in the management of acute non-variceal upper GI bleeding
Joo Ha Hwang, Deborah A. Fisher, Tamir Ben‐Menachem et al. · Gastrointestinal Endoscopy · 2012 · 365 citations · Full text
Medicine, Surgery, Hemostasis +8